FDA Investigator Nicholas Obiri, PhD
Nicholas Obiri, PhD has conducted inspections on 6 sites in 3 countries as of 09 Jul 2001. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
09 Jul 2001
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Puerto Rico,
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Nicholas Obiri, PhD:
Adaliz Santaliz Cruz,
Aikaterini Alexaki,
Alan A Rivera,
Amalia C Himaya,
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Angela K Shen,
Anh M Lac,
Anissa M Cheung,
Anita Narula, PhD,
Arlene M Badillo,
Ashley N Queen, PhD,
Barbara J Wilcox, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brien C Fox,
Burnell M Henry,
Calvin B Koerner,
Carl Lee,
Carla J Lundi,
Carole L Jones,
Caryn M Everly,
Caryn M Mcnab,
Cassandra Overking,
Chava Kimchi Sarfaty, PhD,
Cheron M Portee,
Christina C Santos,
Christina V Santos,
Christopher Downey, PhD,
Christopher R Czajka,
Colleen Thomas, PhD,
Cynthia Jim, CSO,
Daniel J Roberts,
Daniel W Cline,
David S Cho, PhD,
Davinna Ligons, PhD,
Dennis Cantellops Paite,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Donna Ltartaglino Besone,
Dov H Pluznik, PhD,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Dustin R Abaonza,
Eileen A Liu,
Eliezar Ramos,
Emily Shacter,
Eric L Dong, BS,
Erika V Butler,
Esther C Broner, PhD,
Frances Namuswe, PhD,
Gene D Arcy,
Gerald Feldman,
Gerald M Feldman, PhD,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Henry K Lau,
Iris C Macinnes,
Ivis L Negron,
J David Doleski,
Jacqueline Mdiaz Albertini,
James R Evans,
James R Fleckenstein,
Jeanne Fringer, PhD,
Jee Chung, PhD,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer Lalama,
Jennifer M Gogley,
Jerri Baker,
Joan A Loreng,
Joan T Briones,
Joel Welch, PhD,
Joey V Quitania,
John D Finkbohner, PhD,
John M Mcinnis,
John M Mclnnis,
John R Myung,
Jorge L Lajara,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose R Lopez,
Jose Velez,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Joyce A Rockwell,
Junho Pak,
Ka L Wong,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kevin P Foley,
Kim Lthomas Cruse,
Lakisha M Williams,
Lance Mde Souza, MBA,
Laura Fontan, MS,
Laurie P Norwood,
LCDR Jennifer H Rhyu,
Leonard H Lavi,
Lewis K Antwi,
Libia M Lugo,
Linda Thai,
Linh Tu,
LT Rafael Gonzalez,
Mabel M Lee,
Maida Henesian (NMI),
Marcia B Williams,
Marcus F Yambot,
Maria Gutierrez Lugo, PhD,
Marian E Ramirez,
Marie K Kinkade,
Marion Michaelis,
Mariza M Jafary,
Mark A Elengold,
Marsha W Major,
Maxwell Van Tassell, PhD,
Maxyne T Lam,
Michael A Charles,
Michael Shanks, MS,
Michael T Cyrus,
Michele L Forster, PhD,
Michelle A Marsh,
Michelle Rfrazier Jessen, PhD,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milva E Melendez Perales,
Min Shanmabel Liu,
Mohsen Rajabi Abhari, FDA,
Myriam M Sosa,
Natalya M Ananyeva,
Nayan J Patel,
Nicholas L Hunt,
Nicola M Fenty Stewart,
Nikolay Spiridonov,
Noreen Muñiz,
Nydia E Colon,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paul Z Balcer,
Paula A Trost,
Peter E Baker,
Peter Kessler, PhD,
Peter S Diak,
Prabhu P Raju,
Ramesh Potla, PhD,
Ramon A Hernandez,
Raymond T Oji,
Rebecca E Dombrowski,
Rebecca K Olin,
Rebecca Parrilla,
Rebecca Rodriguez,
Rebecca T Davis,
Richmond K Yip,
Riley C Myers, PhD,
Robert D Tollefsen,
Robert Darius,
Robert Jennings,
Robin Levis, PhD,
Roger F Zabinski,
Roman T Drews, PhD,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Rose Ashley,
Sandra S Saniga,
Sarah Arden,
Scott N Lim,
Scott R Nichols, PhD,
Serge L Beaucage,
Sheilyn H Huang,
Shelley H Beausoleil,
Sherri J Jackson,
Sidney B Priesmeyer,
Simone E Pitts,
Sonia R Peterson,
Stanley Au,
Stephanie A Slater, MS,
Steven A Rubin,
Steven C Madzo,
Steven Fong, MS, PhD,
Stuart W Russell,
Susan F Laska, MS,
Susan M Jackson,
Susan Yu,
Svetlana A Shestopal,
Taichun Qin, PhD,
Tamika White,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thea C Grome,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Timothy Wadkin, PhD,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vilmary Negron Rodriguez,
Walden H Lee,
Wendy G Tan, PhD,
William V Millar,
Yi Wang, PhD,
Yumi J Hiramine,
Yvonne C Wilkes,
Zachary L Stamm,
Zhong Li, PhD
Nicholas Obiri, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2001 | FDA 483 | Evans Vaccines Ltd. - Form 483, 2001-05-11 |
October, 2000 | FDA 483 | Amgen, Inc - Form 483, 2000-10-20 |
May, 2001 | FDA 483 Response | Seqirus Vaccines Limited - Form 483R, 2001-05-31 |
January, 2000 | FDA 483 | Genentech, Inc. - Form 483, 2000-01-14 |
May, 2001 | EIR | Seqirus Vaccines Limited - EIR, 2001-05-11 |
July, 2001 | EIR | BAXALTA US INC. - EIR, 2001-07-13 |
January, 2000 | EIR | Genentech, Inc. - EIR, 2000-01-14 |
October, 2000 | EIR | Amgen Manufacturing Limited LLC - EIR, 2000-10-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more